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n this study, the fluoride concentration and pH of 14 commercial brands of mouthrinses were assessed in order
to compare them with the values expressed on the labels and with those established by the National Sanitary
Surveillance Agency. Forty-two (42) products were obtained from three places, with different manufacturing batches.
The fluoride concentration was determined in diluted solutions, using a combined specific electrode for fluoride
ion (9609 BN Orion Research) and ion analyzer (290 A Orion Research). The results showed that 50% of the
solutions had statistically significant differences, with higher fluoride concentrations than those expressed on the
labels, and the pH ranged from 4.23 to 7.34, but only one of the products registered the pH value on its label.
UNITERMS: Topical fluorides; Sodium fluoride; Dental caries.
INTRODUCTION
The role of fluoride as one of the fundamental elements
in the control and prevention of dental caries has been
emphasized since the 1940’s. However, with the introduction
of topical fluoridated products for clinical application, subtle
but significant alterations have occurred with regard to the
most efficient way of using these materials (Heath, et al.6
2001).
Fluoride applied in a topical form is most effective in
controlling dental caries than that acquired pre-eruptively
(Rölla, et al.16 1995), mainly when products are used with
concentrations over 100 ppm F, propitiating the
incorporation of fluoride to the enamel surface in the form
of calcium fluoride, which acts as a reservoir for the slow
fluoride release (Villena, Cury18, 1998).
According to Marinho, et al.10 (2002) the term “topically
applied fluoride” is employed to describe the methods that
release this agent to the exposed dental surfaces, causing a
local protector effect and which therefore is not meant to be
ingested.
Mellberg11 (1990); Di Nicoló, et al.5 (1997) make a
distinction between the topical methods: those for
professional use (highly concentrated solutions, gels and
varnishes) and those for home use (dentifrices and less
concentrated solutions).
The use of fluoride rinses is an additional measure of
protection against caries in adults and children. As regards
the advantages of this method, Adair1 (1998) emphasizes
the stability of formulations (except for stannous fluoride,
according to Mellberg11, 1990), the pleasant taste, absence
of gum irritation and tooth staining, simplicity of use and
low cost.  However, Cury4 (2000) reported that the efficiency
of this method depends on the degree of compliance of the
patient, and the difficulty of establishing a new habit will
demand ability from the professional.
According to Stookey17 (1994), mouthrinses with
fluoridated solutions were originally proposed for public
health programs carried out in schools for daily application
(0.05% sodium fluoride solution) and weekly or fortnightly
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(0.2% sodium fluoride solution). Doubts arose about the
effectiveness of this method in the early 1980’s, due to the
decline in caries, attributed mainly to the use of fluoridated
dentifrices (Ripa15, 1991). Currently, fluoridated solutions
are indicated for patients at high risk and with caries activity,
who may benefit from this method. This category includes
those with active carious lesions, deficient oral hygiene, users
of orthodontic devices or prostheses, patients with exposed
root surfaces, individuals under chemotherapy or
radiotherapy treatment, and patients with decreased salivary
flow (Adair1, 1998; Kumar, Green8, 1998; Heath, et al.6,
2001).
The application of fluoridated rinses is not recommended
for preschool children, who do not have complete control
over the swallowing reflexes and swallow about 20-25% of
the total volume of the solution. The amount of fluoride
swallowed ranges from 0.24-0.44 mg and depends on the
volume of the solution, duration of the mouthrinse and the
child’s age (Stookey17, 1994).
Data have identified fluoridated solutions as a risk factor
for dental fluorosis (Osuji, et al.13 1988); however, this
observation is surprising, since fluorosis is related to the
ingestion of excessive and constant doses of fluoride before
7 years of age, while mouthrinses are indicated for use after
this age (Stookey17, 1994).
According to Newbrun12 (1992) fluoridated rinses were
approved by the FDA (Food and Drug Administration) in
1974 and accepted by the CDT (Council Dental
Therapeutics) in the following year. These products are
available in the following concentrations: 0.05% sodium
fluoride solution for daily use and 0.2% for weekly or
fortnightly use. Neutral solutions containing 0.02% sodium
fluoride were also approved by the FDA, but the main
solutions sold without the need of prescription are those
containing 0.05% sodium fluoride (Winston, Bhaskar20,
1998).
Pierobon, et al.14 (1999) assessed the concentration and
effectiveness of six sodium fluoride solutions prepared by
dispensing pharmacies and  observed significant differences
in the fluoride concentration and reactivity of the products.
According to Heath, et al.6 (2001), with the increasing
use of solutions, gels and varnishes, it is necessary to assure
that the risk of chronic intoxication is not increased. Thus
the clinician must be aware of the dose, the rates relative to
fluoride retention in saliva, risk of ingestion and toxicity of
the fluoridated compounds used in clinics or at home, so
that the fluoride use may be safe and effective.
Based on the assumption that fluoridated solutions used
for mouthrinses are efficient and are an important instrument
for caries prevention, the object of this study was to assess
the concentration of fluoride and the pH of different
mouthrinses sold on the Brazilian market, in order to
compare the values obtained with the values expressed on
the product labels, as well as with those established by the
National Sanitary Surveillance Agency (ANVISA2 in 2000)
MATERIAL AND METHODS
Mouthrinses were acquired in drugstores, supermarkets
and dental products trade establishments (Table 1). Three
products were acquired from each brand, of different
manufacturing batches, purchased in the following places:
Lins (SP), Londrina (PR) and Uberlândia (MG), adding up
to 42 products.
The solutions were coded from 1 to 42, and 1mL of each
product was placed by pipette into a 100-mL volumetric
flask and the volume was made up with deionized water,
obtaining three dilutions for each product. Afterwards, two
(2) 1-mL samples were removed from each dilution and put
into plastic flasks (J-10, Injeplast) totalizing six samples of
each product. The fluoride analysis was performed by means
of a combined specific electrode for fluoride ion 9609 BN
(Orion Research) and ion analyzer 290 A (Orion Research).
A calibration curve was initially made, which ranged from
0.5 to 8.0 ppm F for calculation of the concentration in ppm
F. The fluoride in the solutions was determined after mixing
1mL of the diluted sample with 1mL of TISAB II (buffer
acetate 0.75M, pH 5.0, NaCl 1.0 M and CDTA-
diaminocyclo-hexane-tetra-acetic acid 0.4%), under light
and constant agitation. A new calibration curve was obtained
after every 30 readings, and the electrode was washed with
deionized water and dried with absorbent paper between
readings. The results were shown directly on the ion analyzer
display in millivolts, awaiting stabilization, which varied
according to the fluoride concentration of the sample. The
data obtained were converted into ppm of fluoride.
The pH was determined through the electrometric
method by means of the apparatus pH Meter TEC-2 (Tecnal),
which was calibrated with a standard solution – pH 7.0.
After homogenization (magnetic agitator), 5mL of each
solution was placed in a beaker and the pH reading took 5
minutes after the value was stabilized. The electrode was
washed with deionized water and dried with absorbent paper
at each product change.
Statistical analysis comprised variance analysis
(ANOVA) and the Tukey Test (p<0.05).
RESULTS
The labels of the fluoridated solutions found on the
Brazilian market indicated 0.05% sodium fluoride (226 ppm
F), but one of the brands showed a formulation of 0.05%
fluoride ions, which corresponds to 500 ppm F. The fluoride
concentration of the products analyzed ranged from 224.7
to 567.3 ppm F and rarely coincided with the value on the
label, as 50% of the solutions showed statistically significant
differences, with concentrations above those specified (Table
1).
The pH analysis revealed solutions with pH ranging
between 4.23 and 7.34 (Table 1); however only one of the
commercial brands registered the pH value on its package.
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DISCUSSION
According to the National Sanitary Surveillance Agency
(Agência Nacional de Vigilância Sanitária) ANVISA2
(2000), the solutions called oral mouthrinses belong to a
category of products for dental and oral hygiene. According
to Resolution RDC 79, issued on August 28th 2000, in
Appendix VII,  mandatory items on the product package
are stated as being the product name and group/type to which
it belongs (if this is not implicit in the name), brand, number
of the record/resolution, lot or batch, expiry date (month/
year), content, country of origin, manufacturer/importer,
manufacturer/importer domicile, manner of use, warnings/
restrictions on use, composition/ingredients, inscription in
the National Corporate Tax Register (CNPJ) and purpose
of the product (when not implicit in the name). Furthermore,
in Item D of this appendix on the labels of oral mouthrinses,
the following must specifically be stated: name of the
fluoride compound used, its concentration expressed in ppm
(parts per million), the manner of use and the counter-
indications for children below 6 years of age.
With regard to the risk arising from improper or
accidental use, it was observed that only 4 of the 14 brands
gave this information and only one product did not contain
the specific instruction with regard to use by children under
the age of 6.
Newbrun12 (1992) stated that all packages should contain
legible instructions on their labels, clearly informing the user
to expectorate the solution after mouthrinsing to avoid
swallowing. Like all active pharmacological elements, the
fluoride swallowed in high concentrations may cause
undesirable effects, although the incidence of acute
intoxication by fluoride through mouthrinses is low.
The average concentrations of fluoride in solutions
ranged from 224.7 to 567.4 ppm F (Table 1) and showed
significant statistical differences in relation to the value
specified on the label, as 50% of the solutions showed a
higher concentration than that expressed. Of the 14
commercial brands analyzed, three mouthrinses, S3, S7 and
S12, exceeded the maximum fluoride concentration set by
ANVISA2 (2000), which should be between 202.5 and 247.5
ppm F. The fluoride concentration of S3 and S12 were not
so higher than that set by ANVISA, but S7 exhibits the
double value.
Another surprising data was the fact that the label of
one brand (S7) showed a formulation of 0.05% fluoride ions
for daily mouthrinses, which is not the recommended
concentration (Newbrun12, 1992; Winston, Bhaskar20, 1998).
Furthermore, according to ANVISA2 (2000) the fluoride
concentration should be expressed in ppm on the package,
therefore greater attention should be paid to what is specified
on the product package, as solutions with 0.05% fluoride
Solutions
Fluoride pH
Means ± S.D.* Label Means Label
S1 (Oral B) 225.5 ± 20.1 a 226.0 a 5.62 -
S2 (Fluorsol) 225.3 ± 5.2 a 225.0 a 6.75 -
S3 (Fluordent- Turma da Mônica) ***247.8 ± 7.5 a 226.0 b 5.48 -
S4 (Cepacol Flúor) 226.3 ± 4.9 a 226.0 a 7.34 -
S5 (Cepacol Júnior) 226.3 ± 3.6 a 226.0 a 6.92 -
S6 (Colgate Plax Kids) 227.3 ± 9.2 a 225.0 a 4.63 -
S7 (Fluorstesin) ***567.4 ± 16.7 a 500.0 b 5.55 -
S8 (Colgate Plax) 226.8 ± 4.2 a 225.0 a 6.89 -
S9 (Kolynos Flúor) 235.3 ± 7.7 a 227.0 b 6.51 -
S10 (Sorriso Herbal) 224.7 ± 7.0 a 228.0 a 6.54 -
S11 (Fluotrat) 236.6 ± 5.0 a 226.0 b 5.47 -
S12 (Fluordent Reach) ***248.2 ± 6.7 a 226.0 b 6.90 -
S13 (Reach ER) 246.3 ± 5.0 a 226.0 b 7.00 -
S14 (Fluorgard) 231.8 ± 9.7 a 225.0 b 4.23 4.00
TABLE 1- Comparison between the means of fluoride concentrations (ppm) and mean pH Value of fluoridated mouthrinses
with the values expressed on the labels (n=6**)
The mean fluoride concentrations obtained and the values expressed on the labels of each solution followed by different
letters differ statistically to the level of 5%.
* S.D. = Standard Deviation. ** Numbers of repeated analyses. *** Values above the maximum limit established by ANVISA2
(2000).
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ions have 500 ppm F, differing from those with 0.05% of
sodium fluoride, which have 226 ppm F (Whitford19, 1987).
Considering that the minimum dose capable of causing
toxic signs and symptoms requiring immediate therapeutic
intervention is 5 mg F/Kg of body weight (Whitford19, 1987),
the accidental ingestion of a product with a greater
concentration would increase the risk of acute reaction.
Normally, 10mL of solution are used for mouthrinsing
(Ripa15, 1991; Maltz, Wannmacher9, 1995; Adair1, 1998;
ANVISA2, 2000;); thus, mouthrinses with solutions of 0.05%
sodium fluoride have 2.26mg of fluoride in 10mL, an amount
far from the probably toxic dose, also for lower age brackets.
On the other hand, the commercial brand with 0.05%
fluoride ions for this same volume has 5mg fluoride ions,
consequently care must be taken with the use of this product,
as the ingestion of 200mL would be a probably toxic dose
for a 20-Kg child. The Council Dental Therapeutics (CDT)
of the American Dental Association (ADA) establishes the
maximum value of 120mg of fluoride ions for a flask of
solution, however, the product analyzed containing 0.05%
of fluoride ions was bottled in flasks with a capacity of
500mL, containing an amount of 250mg of fluoride ions
above that allowed by the CDT (Whitford19, 1987).
The pH of the 14 products analyzed ranged from 4.23
to 7.34 and only one of them indicated the pH value on the
label (Table 2), which was considered acidic according to
the analysis performed (pH = 4.23). For Mellberg11 (1990),
lowering the pH in topical fluoride preparations results in
an increase in the calcium fluoride deposition in sound
enamel, but not in etched enamel.  Heimer, Cruz7 (1995)
found that after topical application of four fluoridated
solutions, showing neutral and acid pH, on the human dental
enamel surface in vitro, the amount of calcium fluoride
deposited was extremely reduced, irrespective of the pH of
the solution, suggesting the interference of other components
in the products. According to Barkvoll, et al.3 (1988) many
products currently used in oral hygiene contain lauryl sodium
sulfate as a synthetic detergent, but this component reduced
the deposition of calcium fluoride, probably by increasing
the solubility of this compound in water.
Although the incidence of acute intoxication is low,
mainly if care in administration is taken, adequate instruction
for home use and the assessment of the real need of
additional sources of fluoridated products should be
intensified, especially because these products are sold
without requiring a prescription. In the face of the massive
introduction of fluoridated mouthrinses on the market, the
need for packages to have labels with pertinent
recommendations and the difficult use by children must be
emphasized (Maltz, Wannmacher9, 1995).
Furthermore, when indicating fluoridated mouthrinses,
the professional should know what the specifications on
product labels are, in order to identify the concentration and
amount of fluoride present.
CONCLUSION
The fluoridated solutions analyzed showed a fluoride
concentration similar to or higher than that specified on the
label.
Of the 14 brands analyzed, three products (S3, S7 and
S12) exceeded the limit established by ANVISA (202,5-
247,5 ppm F).
The pH in fluoridated solutions ranged from 4.23 to 7.34,
but only one brand specified this value on its label.
RESUMO
No presente estudo, o teor de flúor e o pH de 14 marcas
comerciais de soluções para bochechos foram avaliados a
fim de comparar com os valores expressos nos rótulos e
com aqueles determinados pela Agência Nacional de
Vigilância Sanitária. Foram adquiridos 42 produtos em três
localidades, com diferentes lotes de fabricação. A
concentração de flúor foi determinada em soluções diluídas,
utilizando-se eletrodo específico combinado para íon flúor
(9609 BN Orion Research) e analisador de íons (290 A Orion
Research). Os resultados mostraram que 50% das soluções
apresentaram diferenças estatisticamente significantes, com
concentrações de flúor superiores àquelas expressas nos
rótulos e o pH variou entre 4,23 a 7,34, mas apenas um dos
produtos registrou o valor do pH em seu rótulo.
UNITERMOS: Fluoretos tópicos; Fluoreto de sódio;
Cárie dentária.
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